Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 15, 2012
Long-term outcome after extensive intestinal resection for chronic radiation enteritisAurelien Amiot, Francisca Joly, Jérémie H Lefevre, et al.
The American Journal of Clinical Nutrition|December 9, 2004
The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation studyYoram Bouhnik, Laurent Raskine, Guy Simoneau, et al.
Inflammatory Bowel Diseases|April 13, 2021
Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's DiseaseHadrien Alric, Aurélien Amiot, Julien Kirchgesner, et al.
Digestive Diseases and Sciences|May 7, 2002
Sugar intolerance: origin and mechanisms of symptoms?Pauline Jouët, Jean-Marc Sabaté, Benoit Coffin, et al.
Alimentary Pharmacology & Therapeutics|April 7, 2020
The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factorHadrien Alric, Aurélien Amiot, Julien Kirchgesner, et al.
Inflammatory Bowel Diseases|August 9, 2022
Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic TreatmentYoram Bouhnik, Raja Atreya, Daniel Casey, et al.
Gastroenterology|February 28, 2007
Capsule endoscopy or push enteroscopy for first-line exploration of obscure gastrointestinal bleeding?Antoine de Leusse, Kouroche Vahedi, Joël Edery, et al.
Inflammatory Bowel Diseases|December 14, 2011
Safety and efficacy of extractible self-expandable metal stents in the treatment of Crohn's disease intestinal strictures: a prospective pilot studyAlain Attar, Vincent Maunoury, Kouroche Vahedi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 24, 2020
The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumabLiza Kassouri, Aurélien Amiot, Julien Kirchgesner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 16, 2014
Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatmentGilles Boschetti, Stéphane Nancey, Driffa Moussata, et al.
Pageof 18